|
临床药师网(linyao.net)免责声明
禁止发布任何可能侵犯版权的内容,否则将承担由此产生的全部侵权后果;提倡文明上网,净化网络环境!抵制低俗不良违法有害信息。
http://www.cnmedex.com/SrcShow.asp?Src_ID=346
The English Pharmacy Board of the Royal Pharmaceutical Society of Great Britain welcomes the government's emphasis on stroke treatment, as outlined in the recent announcement by the Department of Health to boost funding for stroke services.
The number of patients receiving anticoagulation therapy has increased over the last years.
Warfarin, which is used to prevent and treat the formation of harmful blood clots within the body by thinning the blood and/or dissolving clots, plays an important part in part in stroke treatment. Pharmacist management of anticoagulation is routinely offered in many hospital departments and increasingly being carried out by community pharmacists.
Paul Bennett, Chair of the English Pharmacy Board, said: "The government announcement to increase funding for stroke services will improve the support available for stroke survivors and their carers. Specialist pharmacist involvement and pharmacy-run anticoagulant clinics can effectively resolve many of the complex issues in anticoagulant therapy." |
|